Xeloda recently received approval in South Korea for the first-line treatment of patients with locally advanced (metastatic) pancreatic cancer, in combination with gemcitabine.

• 希罗达单药疗法还可用于治疗对紫杉醇和蒽环类抗生素等耐药的晚期原位乳腺癌或转移性乳腺癌患者。